Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Nab-paclitaxel”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)WithdrawnNCT04675450
What this trial is testing

NBP in Women With Metastatic Breast Cancer to Prevent Nab-paclitaxel Induced Toxic Neuropathy

Who this might be right for
Breast CancerPeripheral Neuropathy
Conjupro Biotherapeutics, Inc.
Post-approval studies (Phase 4)UnknownNCT04182568
What this trial is testing

Nab-paclitaxel Compared With Docetaxel Followed by Anthracyclines and Cyclophosphamide in the Neoadjuvant Breast Cancer

Who this might be right for
Breast Cancer
Xijing Hospital 100
Testing effectiveness (Phase 2)Ended earlyNCT02322814
What this trial is testing

Cobimetinib Plus Paclitaxel, Cobimetinib Plus Atezolizumab Plus Paclitaxel, or Cobimetinib Plus Atezolizumab Plus Nab-Paclitaxel as Initial Treatment for Participants With Triple-Negative Breast Cancer That Has Spread

Who this might be right for
Breast Cancer
Hoffmann-La Roche 169
Testing effectiveness (Phase 2)Study completedNCT03830606
What this trial is testing

The Efficacy and Safety of Nab-paclitaxel Plus S-1 in First-line Treatment of Advanced Biliary Tract Adenocarcinoma

Who this might be right for
Biliary Tract Cancer
Aiping Zhou 54
Post-approval studies (Phase 4)UnknownNCT03799692
What this trial is testing

Albumin-Bound Paclitaxel Combined With Carboplatin as Neoadjuvant Chemotherapy in Luminal B/HER-2 Negative Breast Cancer

Who this might be right for
HER-2 Negative Breast Cancer
Fudan University 78
Testing effectiveness (Phase 2)Study completedNCT02733250
What this trial is testing

Pembrolizumab With Nab-Paclitaxel in Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Centre hospitalier de l'Université de Montréal (CHUM) 10
Testing effectiveness (Phase 2)Looking for participantsNCT06423326
What this trial is testing

Gemcitabine, Cisplatin and Nab-Paclitaxel as Neoadjuvant Treatment for Patients With Resectable or Borderline Resectable Pancreatic Cancer

Who this might be right for
Borderline Resectable Pancreatic Ductal AdenocarcinomaResectable Pancreatic AdenocarcinomaStage I Pancreatic Cancer AJCC v8+2 more
Emory University 36
Testing effectiveness (Phase 2)Looking for participantsNCT07601178
What this trial is testing

QUEEN-APPLE: A Single-Arm, Multicenter, Prospective Phase II Clinical Study of Iparomlimab and Tuvonralimab (QL1706) in Combination With Anlotinib Hydrochloride and Nab-Paclitaxel as First-Line Treatment for Advanced Triple-Negative Breast Cancer

Who this might be right for
TNBC, Triple Negative Breast Cancer
Jiangsu Cancer Institute & Hospital 34
Large-scale testing (Phase 3)Study completedNCT03197935
What this trial is testing

Investigate Atezolizumab and Chemotherapy Compared With Placebo and Chemotherapy in the Neoadjuvant Setting in Participants With Early Stage Triple Negative Breast Cancer

Who this might be right for
Triple-negative Breast Cancer
Hoffmann-La Roche 333
Early research (Phase 1)UnknownNCT03703089
What this trial is testing

Gemcitabine & Nab-Paclitaxel in Pancreatic Adenocarcinoma With Positive Peritoneal Cytology

Who this might be right for
Pancreatic Adenocarcinoma
Benaroya Research Institute 21
Testing effectiveness (Phase 2)Looking for participantsNCT06483555
What this trial is testing

Basal-like PDAC Treated With Gemcitabine, Erlotinib, and Nab-paclitaxel

Who this might be right for
Pancreatic AdenocarcinomaMetastatic Pancreatic CancerBasal Cell Neoplasm
UNC Lineberger Comprehensive Cancer Center 104
Testing effectiveness (Phase 2)UnknownNCT05547828
What this trial is testing

Efficacy and Safety of Tislelizumab and Nab-paclitaxel Combined With Low-dose Radiotherapy in Patients With Stage IVb Esophageal Squamous Cell Carcinoma

Who this might be right for
ESCC
The First Affiliated Hospital of Xinxiang Medical College 20
Testing effectiveness (Phase 2)UnknownNCT04211012
What this trial is testing

A Study on Toripalimab Plus Nab-Paclitaxel With or Without Cisplatin as First-line Treatment of Urothelial Carcinoma

Who this might be right for
Urothelial Carcinoma
Jun Guo 30
Testing effectiveness (Phase 2)UnknownNCT05346107
What this trial is testing

PLD-cyclophosphamide-Nab-P Continuously Combined With Dual HER2 Blockage for HER2-positive Breast Cancer

Who this might be right for
Breast CancerHER2-positive Breast Cancer
Xijing Hospital 100
Testing effectiveness (Phase 2)Not Yet RecruitingNCT04825938
What this trial is testing

Neoadjuvant Toripalimab in Combination With Carboplatin and Nab-paclitaxel in Untreated Salivary Gland Malignant Neoplasms

Who this might be right for
Salivary Gland Malignant NeoplasmsSalivary Gland Tumors
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 15
Testing effectiveness (Phase 2)Ended earlyNCT02732938
What this trial is testing

Ph1b/2 Study of PF-04136309 in Combination With Gem/Nab-P in First-line Metastatic Pancreatic Patients

Who this might be right for
Metastatic Pancreatic Ductal Adenocarcinoma
Pfizer 22
Testing effectiveness (Phase 2)UnknownNCT03850769
What this trial is testing

Neoadjuvant Nab-Paclitaxel and S-1 in Borderline Resectable Pancreatic Cancer

Who this might be right for
Borderline Resectable Pancreatic Cancer
Peking Union Medical College Hospital 60
Testing effectiveness (Phase 2)Active Not RecruitingNCT04753879
What this trial is testing

Multi-agent Low Dose Chemotherapy GAX-CI Followed by Olaparib and Pembro in Metastatic Pancreatic Ductal Cancer.

Who this might be right for
Metastatic Pancreatic Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 38
Testing effectiveness (Phase 2)Looking for participantsNCT07043270
What this trial is testing

24BRO681 : Alternating Gnp and mFOLFIRINOX for BR-PDAC

Who this might be right for
Pancreas Adenocarcinoma
Dartmouth-Hitchcock Medical Center 35
Early research (Phase 1)Study completedNCT04306900
What this trial is testing

TTX-030 in Combination With Immunotherapy and/or Chemotherapy in Subjects With Advanced Cancers

Who this might be right for
Solid Tumor, Adult
Trishula Therapeutics, Inc. 185
Next Page